Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis

Condition:   Cystic Fibrosis Interventions:   Drug: PTI-808;   Drug: Placebo;   Drug: PTI-801;   Drug: PTI-428 Sponsor:   Proteostasis Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials